| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2016 | IMQUEST BIOSCIENCES, INC. | 7340 EXECUTIVE WAY STE R | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 5 | NIH | 5/2/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2016 | IMQUEST BIOSCIENCES, INC. | 7340 EXECUTIVE WAY STE R | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 001 | 5 | NIH | 1/18/2017 | $1,354,934 |
| | 2017 | 2015 | IMQUEST BIOSCIENCES, INC. | 7340 EXECUTIVE WAY STE R | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 4 | NIH | 1/18/2017 | -$1,354,934 |
| | 2017 | 2012 | IMQUEST BIOSCIENCES, INC. | 7340 EXECUTIVE WAY STE R | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI077289 | Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic | 000 | 5 | NIH | 1/31/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $2,149,121 ) |
| | 2016 | 2016 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 5 | NIH | 5/20/2016 | $2,149,121 |
|
| Issue Date FY: 2015 ( Subtotal = $2,443,193 ) |
| | 2015 | 2015 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 4 | NIH | 4/29/2015 | $2,443,193 |
|
| Issue Date FY: 2014 ( Subtotal = $3,267,425 ) |
| | 2014 | 2014 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R33AI088586 | Development of a novel nanoparticle pyrimidinedione vaginal polymeric film as an | 000 | 5 | NIH | 7/18/2014 | $391,072 |
| | 2014 | 2014 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 3 | NIH | 6/5/2014 | $2,876,353 |
|
| Issue Date FY: 2013 ( Subtotal = $3,942,172 ) |
| | 2013 | 2013 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R33AI088586 | Development of a novel nanoparticle pyrimidinedione vaginal polymeric film as an | 000 | 4 | NIH | 7/25/2013 | $368,105 |
| | 2013 | 2013 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 2 | NIH | 7/10/2013 | $3,574,067 |
|
| Issue Date FY: 2012 ( Subtotal = $4,678,821 ) |
| | 2012 | 2012 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI101961 | Development and Evaluation of Dual Compartment Combination Microbicides | 000 | 1 | NIH | 6/20/2012 | $3,224,012 |
| | 2012 | 2012 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R33AI088586 | Development of a novel nanoparticle pyrimidinedione vaginal polymeric film as an | 000 | 3 | NIH | 7/26/2012 | $374,101 |
| | 2012 | 2012 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI077289 | Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic | 000 | 5 | NIH | 4/20/2012 | $1,080,708 |
| | 2012 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704 | FREDERICK | USA | R33AI076967 | RATIONAL DEVELOPMENT OF COMBINATION MICROBICIDE THERAPIES | 000 | 5 | NIH | 7/25/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $2,507,186 ) |
| | 2011 | 2011 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI082689 | DEVELOPMENT OF ANTIMICROBIAL PEPTIDES AS TOPICAL MICROBICIDES | 000 | 2 | NIH | 7/21/2011 | $173,689 |
| | 2011 | 2011 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI077289 | Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic | 000 | 4 | NIH | 7/22/2011 | $1,265,859 |
| | 2011 | 2011 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R44AI078858 | MECHANISM OF ACTION OF NOVEL DUAL ACTING PYRIMIDINEDIONES | 000 | 3 | NIH | 7/8/2011 | $861,701 |
| | 2011 | 2011 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI088586 | DEVELOPMENT OF A NOVEL NANOPARTICLE PYRIMIDINEDIONE VAGINAL POLYMERIC FILM AS AN | 000 | 2 | NIH | 7/21/2011 | $21,429 |
| | 2011 | 2011 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI088586 | DEVELOPMENT OF A NOVEL NANOPARTICLE PYRIMIDINEDIONE VAGINAL POLYMERIC FILM AS AN | 000 | 2 | NIH | 7/21/2011 | $163,080 |
| | 2011 | 2011 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI082689 | DEVELOPMENT OF ANTIMICROBIAL PEPTIDES AS TOPICAL MICROBICIDES | 000 | 2 | NIH | 7/21/2011 | $21,428 |
|
| Issue Date FY: 2010 ( Subtotal = $3,825,821 ) |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R43AI089331 | DEVELOPMENT OF TRANSDERMAL FILMS FOR THE THE DELIVERY OF HIV THERAPEUTICS | 000 | 1 | NIH | 6/8/2010 | $301,470 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI077289 | Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic | 000 | 3 | NIH | 7/2/2010 | $1,578,326 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R44AI078858 | MECHANISM OF ACTION OF NOVEL DUAL ACTING PYRIMIDINEDIONES | 000 | 2 | NIH | 5/31/2010 | $919,455 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R33AI076967 | RATIONAL DEVELOPMENT OF COMBINATION MICROBICIDE THERAPIES | 000 | 5 | NIH | 8/27/2010 | $426,388 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI079772 | DEVELOPMENT OF A NOVEL SEMEN-ACTIVATED PRODRUG AS AN ANTI-HIV MICROBICIDE | 001 | 2 | NIH | 8/11/2010 | $167,087 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI088586 | DEVELOPMENT OF A NOVEL NANOPARTICLE PYRIMIDINEDIONE VAGINAL POLYMERIC FILM AS AN | 000 | 1 | NIH | 6/17/2010 | $195,146 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI088586 | DEVELOPMENT OF A NOVEL NANOPARTICLE PYRIMIDINEDIONE VAGINAL POLYMERIC FILM AS AN | 001 | 1 | NIH | 8/12/2010 | $21,428 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI088586 | DEVELOPMENT OF A NOVEL NANOPARTICLE PYRIMIDINEDIONE VAGINAL POLYMERIC FILM AS AN | 001 | 1 | NIH | 8/12/2010 | -$21,428 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI082689 | DEVELOPMENT OF ANTIMICROBIAL PEPTIDES AS TOPICAL MICROBICIDES | 000 | 1 | NIH | 6/17/2010 | $200,449 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI082689 | DEVELOPMENT OF ANTIMICROBIAL PEPTIDES AS TOPICAL MICROBICIDES | 001 | 1 | NIH | 8/12/2010 | $21,428 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI082689 | DEVELOPMENT OF ANTIMICROBIAL PEPTIDES AS TOPICAL MICROBICIDES | 001 | 1 | NIH | 8/12/2010 | -$21,428 |
| | 2010 | 2010 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI079772 | DEVELOPMENT OF A NOVEL SEMEN-ACTIVATED PRODRUG AS AN ANTI-HIV MICROBICIDE | 001 | 2 | NIH | 8/11/2010 | $37,500 |
| | 2010 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704 | FREDERICK | USA | R21AI079772 | DEVELOPMENT OF A NOVEL SEMEN-ACTIVATED PRODRUG AS AN ANTI-HIV MICROBICIDE | 000 | 1 | NIH | 7/14/2010 | $0 |
| | 2010 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704 | FREDERICK | USA | R21AI079772 | DEVELOPMENT OF A NOVEL SEMEN-ACTIVATED PRODRUG AS AN ANTI-HIV MICROBICIDE | 000 | 1 | NIH | 7/14/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $2,383,831 ) (Continued on the next page) |
| | 2009 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R43AI084676 | DEVELOPMENT OF PYRIMIDINEDIONE NNRTIS WITH A HIGH GENETIC BARRIER TO RESISTANCE | 000 | 1 | NIH | 8/31/2009 | $231,102 |
| | 2009 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI079772 | DEVELOPMENT OF A NOVEL SEMEN-ACTIVATED PRODRUG AS AN ANTI-HIV MICROBICIDE | 000 | 1 | NIH | 9/2/2009 | $148,736 |
| | 2009 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | U19AI077289 | Long Acting Acceptable Microbicides: Novel Delivery, Activity and Pharmacodynamic | 000 | 2 | NIH | 8/6/2009 | $1,389,746 |
| | 2009 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R21AI079772 | DEVELOPMENT OF A NOVEL SEMEN-ACTIVATED PRODRUG AS AN ANTI-HIV MICROBICIDE | 000 | 1 | NIH | 9/2/2009 | $37,500 |
| | 2009 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R33AI076967 | RATIONAL DEVELOPMENT OF COMBINATION MICROBICIDE THERAPIES | 000 | 4 | NIH | 9/18/2009 | $435,378 |
| | 2009 | 2009 | IMQUEST BIOSCIENCES INC | 7340 EXECUTIVE WAY | FREDERICK | MD | 21704-9405 | FREDERICK | USA | R43AI082788 | DEVELOPMENT OF NOVEL HEPATITS C VIRUS INHIBITORS | 000 | 1 | NIH | 2/3/2009 | $141,369 |
|
